uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
March 02, 2020 16:05 ET
|
uniQure Inc.
~ Patient Dosing Nearly Completed in Phase III HOPE-B Trial of Etranacogene Dezaparvovecin Hemophilia B ~ ~ First Patient Procedure in Phase I/II Clinical Trial of AMT-130 in Huntington’s Disease...
ATN Reports Fourth Quarter and Full Year 2019 Results
February 19, 2020 17:01 ET
|
ATN International, Inc.
Continued growth in domestic and international telecom drives improved underlying operating resultsTelecom businesses well positioned to continue to deliver strong financial performance in 2020 ...